Table 2. Multivariable log-binomial regression of characteristics for 333 persons from 25 US jurisdictions who were diagnosed with TB–COVID-19 in 2020 and persons with TB only diagnosed in 2017‒2019 or in 2020*.

Characteristic	2020 TB only			2017‒2019 TB only
	uPR (95% CI)	aPR (95% CI)		uPR (95% CI)	aPR (95% CI)
Race/ethnicity†
White	Referent	Referent		Referent	Referent
Black	0.8 (0.6‒1.1)	1.1 (0.7‒1.7)		0.9 (0.6‒1.1)	1.2 (0.7‒1.9)
Asian	0.7 (0.6‒0.9)	0.8 (0.5‒1.2)		0.7 (0.6‒0.9)	0.8 (0.5‒1.3)
Hispanic	1.6 (1.3‒2.0)	1.4 (0.9‒2.2)		1.6 (1.3‒1.9)	1.4 (0.9‒2.2)
NHOPI	2.4 (1.1‒5.4)	2.3 (1.0‒5.3)		2.2 (0.9‒5.2)	2.9 (1.1‒7.4)
American Indian/Alaska Native	3.4 (1.4‒8.1)	5.3 (2.1‒13.4)		2.3 (0.9‒6.0)	3.4 (1.2‒9.6)
Origin of birth
US-born	Referent	Referent		Referent	Referent
Non–US-born	1.4 (1.1‒1.8)	1.5 (1.1‒2.1)		1.5 (1.1‒1.9)	1.6 (1.1‒2.2)
AFB sputum smear result
Negative	Referent	NI		Referent	Referent
Positive	1.3 (1.0‒1.5)			1.4 (1.1‒1.7)	1.3 (1.0‒1.6)
Missing/Unknown	0.9 (0.7‒1.2)			0.9 (0.7‒1.2)	1.0 (0.7‒1.5)
Long-term care resident at TB diagnosis‡
No	Referent	Referent		Referent	Referent
Yes	2.6 (1.6‒4.2)	2.5 (1.6‒4.0)		2.5 (1.5‒4.1)	2.4 (1.4‒4.0)
Diabetes
No	Referent	Referent		Referent	Referent
Yes	1.8 (1.4‒2.2)	1.6 (1.3‒2.0)		2.0 (1.6‒2.5)	1.8 (1.4‒2.2)
End-stage renal disease
No	Referent	NI		Referent	Referent
Yes	1.8 (1.2‒2.7)			2.2 (1.4‒3.4)	1.7 (1.1‒2.7)

*Model adjusted for other variables in the table. aPR, adjusted prevalence ratio; AFB, acid-fast bacilli; NHOPI, Native Hawaiian and Other Pacific Islander; NI, not included in adjusted regression model because not statistically significant at 95% confidence level; TB, tuberculosis; TB–COVID-19, diagnosed with both TB and COVID-19 within 180 days; uPR, unadjusted prevalence ratio. †Multiple race category not included because no persons with TB–COVID-19 reported multiple races. ‡Among persons >15 years of age.